Aclarion (NASDAQ:ACON – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.
Institutional & Insider Ownership
7.5% of Aclarion shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 0.0% of Aclarion shares are held by company insiders. Comparatively, 0.7% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Aclarion and Teladoc Health”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Aclarion | $80,000.00 | 107.63 | -$7.23 million | ($9.03) | -0.39 |
| Teladoc Health | $2.53 billion | 0.54 | -$200.32 million | ($0.97) | -7.79 |
Aclarion has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Aclarion, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Aclarion and Teladoc Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Aclarion | 1 | 0 | 1 | 0 | 2.00 |
| Teladoc Health | 1 | 11 | 5 | 0 | 2.24 |
Aclarion currently has a consensus price target of $7.50, indicating a potential upside of 114.29%. Teladoc Health has a consensus price target of $7.43, indicating a potential downside of 1.61%. Given Aclarion’s higher possible upside, equities research analysts plainly believe Aclarion is more favorable than Teladoc Health.
Volatility & Risk
Aclarion has a beta of 1.22, suggesting that its stock price is 22% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500.
Profitability
This table compares Aclarion and Teladoc Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Aclarion | -10,320.51% | -54.41% | -51.71% |
| Teladoc Health | -6.81% | -11.45% | -5.54% |
Summary
Teladoc Health beats Aclarion on 10 of the 14 factors compared between the two stocks.
About Aclarion
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
About Teladoc Health
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
